Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis

British Journal of Haematology

Volumn 163, Issue 3, 2013, Pages 326-333

  Greipp, Patricia T ^a   Smoley, Stephanie A ^a   Viswanatha, David S ^b   Frederick, Lori S ^b   Rabe, Kari G ^b   Sharma, Ruchi G ^b   Slager, Susan L ^b   Van Dyke, Daniel L ^a   Shanafelt, Tait D ^b   Tschumper, Renee C ^c   Zent, Clive S ^c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

ATM; Chronic lymphocytic leukaemia; Fluorescence in situ hybridization (FISH); Prognostic factors; TP53

Indexed keywords

ATM PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLONAL VARIATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME;

ATM; CHRONIC LYMPHOCYTIC LEUKAEMIA; FLUORESCENCE IN SITU HYBRIDIZATION (FISH); PROGNOSTIC FACTORS; TP53;

ADULT; AGED; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CLONE CELLS; FEMALE; GENES, NEOPLASM; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885429353     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12534     Document Type: Article

References (14)

1. Austen, B., Skowronska, A., Baker, C., Powell, J.E., Gardiner, A., Oscier, D., Majid, A., Dyer, M., Siebert, R., Taylor, A.M., Moss, P.A. & Stankovic, T. (2007) Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. Journal of Clinical Oncology, 25, 5448-5457.
2. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
3. Dewald, G.W., Brockman, S.R., Paternoster, S.F., Bone, N.D., O'Fallon, J.R., Allmer, C., James, C.D., Jelinek, D.F., Tschumper, R.C., Hanson, C.A., Pruthi, R.K., Witzig, T.E., Call, T.G. & Kay, N.E. (2003) Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 121, 287-295.
4. Dicker, F., Herholz, H., Schnittger, S., Nakao, A., Patten, N., Wu, L., Kern, W., Haferlach, T. & Haferlach, C. (2009) The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia, 23, 117-124.
5. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
6. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1910-1916.
7. Hamblin, T., Davis, Z., Gardiner, A., Oscier, D. & Stevenson, F. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-1854.
8. Ouillette, P., Li, J., Shaknovich, R., Li, Y., Melnick, A., Shedden, K. & Malek, S.N. (2012) Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia. Genes, Chromosomes & Cancer, 51, 1125-1132.
9. Pospisilova, S., Gonzalez, D., Malcikova, J., Trbusek, M., Rossi, D., Kater, A.P., Cymbalista, F., Eichhorst, B., Hallek, M., Dohner, H., Hillmen, P., van Oers, M., Gribben, J., Ghia, P., Montserrat, E., Stilgenbauer, S. & Zenz, T. (2012) ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia, 26, 1458-1461.
10. Rossi, D., Cerri, M., Deambrogi, C., Sozzi, E., Cresta, S., Rasi, S., De Paoli, L., Spina, V., Gattei, V., Capello, D., Forconi, F., Lauria, F. & Gaidano, G. (2009) The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. Clinical Cancer Research, 15, 995-1004.
11. Skowronska, A., Parker, A., Ahmed, G., Oldreive, C., Davis, Z., Richards, S., Dyer, M., Matutes, E., Gonzalez, D., Taylor, A.M., Moss, P., Thomas, P., Oscier, D. & Stankovic, T. (2012) Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial. Journal of Clinical Oncology, 30, 4524-4532.
12. Stilgenbauer, S. & Zenz, T. (2010) Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology/the Education Program of the American Society of Hematology, 2010, 481-488.
13. Zenz, T., Krober, A., Scherer, K., Habe, S., Buhler, A., Benner, A., Denzel, T., Winkler, D., Edelmann, J., Schwanen, C., Dohner, H. & Stilgenbauer, S. (2008) Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood, 112, 3322-3329.
14. Zenz, T., Eichhorst, B., Busch, R., Denzel, T., Habe, S., Winkler, D., Buhler, A., Edelmann, J., Bergmann, M., Hopfinger, G., Hensel, M., Hallek, M., Dohner, H. & Stilgenbauer, S. (2010) TP53 mutation and survival in chronic lymphocytic leukemia. Journal of Clinical Oncology, 28, 4473-4479.